Alpa Laboratories Limited (NSE:ALPA)
63.93
-1.29 (-1.98%)
At close: Jan 23, 2026
Alpa Laboratories Revenue
Alpa Laboratories had revenue of 262.58M INR in the quarter ending September 30, 2025, with 5.29% growth. This brings the company's revenue in the last twelve months to 1.11B, up 14.53% year-over-year. In the fiscal year ending March 31, 2025, Alpa Laboratories had annual revenue of 1.12B with 3.41% growth.
Revenue (ttm)
1.11B
Revenue Growth
+14.53%
P/S Ratio
1.21
Revenue / Employee
2.46M
Employees
453
Market Cap
1.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
| Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
| Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
| Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
| Mar 31, 2021 | 975.54M | 115.85M | 13.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 5.72B |
| Sigachi Industries | 5.09B |
| Sakar Healthcare | 2.04B |
| Valiant Laboratories | 1.86B |
| Bafna Pharmaceuticals | 1.42B |
| Vaishali Pharma | 1.17B |
| Vivimed Labs | 1.09B |